Compare VCYT & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCYT | ETY |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2013 | N/A |
| Metric | VCYT | ETY |
|---|---|---|
| Price | $41.73 | $15.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $46.00 | N/A |
| AVG Volume (30 Days) | ★ 670.0K | 247.3K |
| Earning Date | 02-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.21% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $495,141,000.00 | N/A |
| Revenue This Year | $16.46 | N/A |
| Revenue Next Year | $11.37 | N/A |
| P/E Ratio | $109.27 | ★ N/A |
| Revenue Growth | ★ 16.41 | N/A |
| 52 Week Low | $22.61 | $10.59 |
| 52 Week High | $50.71 | $13.46 |
| Indicator | VCYT | ETY |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 35.50 |
| Support Level | $40.29 | $15.20 |
| Resistance Level | $44.59 | $15.60 |
| Average True Range (ATR) | 1.69 | 0.17 |
| MACD | -0.27 | -0.03 |
| Stochastic Oscillator | 20.42 | 6.14 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.